Gene · 23705
Papers3,480
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 3,480
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Androgen Receptor-Positive TNBC. | Dis Markers | 2022 | 36157217 | PubTator, text mining | PubMed |
| Host cell membrane proteins located near SARS-CoV-2 spike protein attachment sites are identified using proximity labeling and proteomic analysis. | J Biol Chem | 2022 | 36152751 | PubTator, text mining | PubMed |
| Phellopterin cream exerts an anti-inflammatory effect that facilitates diabetes-associated cutaneous wound healing via SIRT1. | Phytomedicine | 2022 | 36150345 | PubTator, text mining | PubMed |
| Exome-Wide Association Study Reveals Host Genetic Variants Likely Associated with the Severity of COVID-19 in Patients of European Ancestry. | Life (Basel) | 2022 | 36143338 | PubTator, text mining | PubMed |
| Lung Ultrasound Findings and Endothelial Perturbation in a COVID-19 Low-Intensity Care Unit. | J Clin Med | 2022 | 36143072 | PubTator, text mining | PubMed |
| Characterization of miRNAs in Milk Small Extracellular Vesicles from Enzootic Bovine Leukosis Cattle. | Int J Mol Sci | 2022 | 36142686 | PubTator, text mining | PubMed |
| Rebooting Regulatory T Cell and Dendritic Cell Function in Immune-Mediated Inflammatory Diseases: Biomarker and Therapy Discovery under a Multi-Omics Lens. | Biomedicines | 2022 | 36140240 | PubTator, text mining | PubMed |
| Drug repurposing as a potential source of innovative therapies in cervical cancer. | Int J Gynecol Cancer | 2022 | 36137575 | PubTator, text mining | PubMed |
| Pan-cancer gene expression analysis of tissue microarray using EdgeSeq oncology biomarker panel and a cross-comparison with HER2 and HER3 immunohistochemical analysis. | PLoS One | 2022 | 36137139 | PubTator, text mining | PubMed |
| Nasopharyngeal Carcinoma Progression: Accumulating Genomic Instability and Persistent Epstein-Barr Virus Infection. | Curr Oncol | 2022 | 36135044 | PubTator, text mining | PubMed |
| Non-typeable Haemophilus influenzae airways infection: the next treatable trait in asthma? | Eur Respir Rev | 2022 | 36130784 | PubTator, text mining | PubMed |
| African Ancestry-Associated Gene Expression Profiles in Triple-Negative Breast Cancer Underlie Altered Tumor Biology and Clinical Outcome in Women of African Descent. | Cancer Discov | 2022 | 36121736 | PubTator, text mining | PubMed |
| CCL-2 and CXCL-8: Potential Prognostic Biomarkers of Acute Kidney Injury after a Bothrops atrox Snakebite. | Mediators Inflamm | 2022 | 36117588 | PubTator, text mining | PubMed |
| Targeting SARS-CoV-2 papain-like protease in the postvaccine era. | Trends Pharmacol Sci | 2022 | 36114026 | PubTator, text mining | PubMed |
| ST6Gal1: Oncogenic signaling pathways and targets. | Front Mol Biosci | 2022 | 36106023 | PubTator, text mining | PubMed |
| DNA methylation alterations caused by Leishmania infection may generate a microenvironment prone to tumour development. | Front Cell Infect Microbiol | 2022 | 36105147 | PubTator, text mining | PubMed |
| A novel biomarker NIFK-AS1 promotes hepatocellular carcinoma cell cycle progression through interaction with SRSF10. | J Gastrointest Oncol | 2022 | 36092356 | PubTator, text mining | PubMed |
| Cell adhesion molecules E-cadherin and CADM1 are differently expressed in canine inflammatory mammary cancer. | Res Vet Sci | 2022 | 36084372 | PubTator, text mining | PubMed |
| Omics Analysis of Chemoresistant Triple Negative Breast Cancer Cells Reveals Novel Metabolic Vulnerabilities. | Cells | 2022 | 36078127 | PubTator, text mining | PubMed |
| Prognostic Capability of TNBC 3-Gene Score among Triple-Negative Breast Cancer Subtypes. | Cancers (Basel) | 2022 | 36077821 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23705/papers?page=30